COST-EFFECTIVENESS OF A NEW FIXED-DOSE COMBINATION OF DUTASTERIDE AND TAMSULOSIN FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA IN QUEBEC, CANADA

被引：0
|
作者：
Ismaila, A. [1 ]
Posnett, J. [2 ]
Walker, A. [2 ]
Sayani, A. [1 ]
Laroche, B. [3 ]
Nickel, J. C. [4 ]
Robson, R. C. [1 ]
Su, Z. [1 ]
机构：
[1] GlaxoSmithKline Inc, Mississauga, ON, Canada
[2] Heron Evidence Dev Ltd, Luton, Beds, England
[3] Hop St Francois Assise, Quebec City, PQ, Canada
[4] Queens Univ, Kingston, ON, Canada
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1048
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A194 / A194
页数：1
相关论文
共 50 条
  • [41] Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
    Basiri, Abbas
    Zare, Rasool
    Zahir, Mazyar
    Kashi, Amir Hossein
    Zobeiry, Mahsa
    Borumandnia, Nasrin
    Abedi, Amir Reza
    Golshan, Shabnam
    AFRICAN JOURNAL OF UROLOGY, 2024, 30 (01)
  • [42] COST-EFFECTIVENESS OF COMBINATION THERAPY WITH DUTASTERIDE/TAMSULOSIN: AN ANALYSIS BASED ON CONDUCT TRIAL
    Vallejo-Aparicio, L. A.
    Minana Lopez, B.
    Brenes, F. J.
    Molero, J. M.
    Fernandez-Pro, A.
    Huerta, A.
    Cozar, J. M.
    VALUE IN HEALTH, 2016, 19 (07) : A518 - A518
  • [43] Tamsulosin and Solifenacin in the treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
    Wang, Hui
    Chang, Yanhua
    Liang, Hui
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 988 - 992
  • [44] Efficacy of Low-Dose Tamsulosin in Chinese Patients with Symptomatic Benign Prostatic Hyperplasia
    Ning-Chen Li
    Shan Chen
    Xue-Hui Yang
    Lin-Dong Du
    Jian-Ye Wang
    Yan-Qun Na
    Clinical Drug Investigation, 2003, 23 : 781 - 787
  • [45] Efficacy of low-dose tamsulosin in chinese patients with symptomatic benign prostatic hyperplasia
    Li, NC
    Chen, S
    Yang, XH
    Du, LD
    Wang, JY
    Na, YQ
    CLINICAL DRUG INVESTIGATION, 2003, 23 (12) : 781 - 787
  • [46] Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
    Zhou, Zhongbao
    Cui, Yuanshan
    Wu, Jitao
    Ding, Rui
    Cai, Tong
    Gao, Zhenli
    BMC UROLOGY, 2019, 19 (1)
  • [47] The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia
    Hillman, AL
    Schwartz, JS
    Willian, MK
    Peskin, E
    Roehrborn, CG
    Oesterling, JE
    Mason, MF
    Maurath, CJ
    Deverka, PA
    Padley, RJ
    UROLOGY, 1996, 47 (02) : 169 - 178
  • [48] Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
    Zhongbao Zhou
    Yuanshan Cui
    Jitao Wu
    Rui Ding
    Tong Cai
    Zhenli Gao
    BMC Urology, 19
  • [49] EFFECTS OF COMBINATION THERAPY WITH DUTASTERIDE AND TAMSULOSIN ON CLINICAL OUTCOMES IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA FOUR YEAR RESULTS FROM THE COMBAT STUDY
    Roehrborn, C. G.
    Barkin, J.
    Siami, P.
    Tubaro, A.
    Damiao, R.
    Gagnier, R. P.
    Castro, R.
    Morrill, B.
    Nandy, I.
    Montorsi, F.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 268 - 268
  • [50] Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
    Eisen, Christoph
    Lulic, Zrinka
    Manuel Palacios-Moreno, Juan
    Adalig, Burkay
    Hennig, Michael
    Cortes, Vanessa
    Gilg, Florian
    Kostev, Karel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (01) : 37 - 49
12345